SEC Filings

Filing date	Form	Description	View
04/29/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-012708.pdf 0001047469-16-012708.rtf 0001047469-16-012708.xls
04/29/16	FWP	FWP	View HTML 0001104659-16-115511.pdf 0001104659-16-115511.rtf 0001104659-16-115511.xls
04/27/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-012613.pdf 0001047469-16-012613.rtf 0001047469-16-012613.xls
03/25/16	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-16-011603.pdf 0001047469-16-011603.rtf 0001047469-16-011603.xls
03/24/16	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	View HTML 0000903423-16-000939.pdf 0000903423-16-000939.rtf 0000903423-16-000939.xls
03/17/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-021849.pdf 0001179110-16-021849.rtf 0001179110-16-021849.xls
03/17/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-021850.pdf 0001179110-16-021850.rtf 0001179110-16-021850.xls
03/17/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-021851.pdf 0001179110-16-021851.rtf 0001179110-16-021851.xls
03/17/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-021856.pdf 0001179110-16-021856.rtf 0001179110-16-021856.xls
03/17/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-021855.pdf 0001179110-16-021855.rtf 0001179110-16-021855.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.